SEOUL, Sept. 21 (Xinhua) -- South Korea's Green Cross Corp. said Monday that it signed a contract worth 42.6 billion won, or 35.3 million U.S. dollars with the South Korean government on providing 5.86 million doses of its A /H1N1 vaccine.
According to Green Cross, the company will provide the government with flu vaccines by the end of November.
The South Korean government announced that it plans to have some 13.4 million people, or 27 percent of the nation's population, inoculated by next February.
Meanwhile, another local drug maker, Boryung Pharmaceutical Co., said last Thursday that it filed for selling a Chinese-made vaccine for the flu in South Korea within this year.
Settling a deal with China's Sinovac Biotech Ltd. earlier this month, the company will import as many as 10 million doses of the vaccine, enough to inoculate some 5 million people.
As of Sept. 13, 9,968 patients were confirmed to be infected with the deadly virus, which has reportedly been related to death of nine South Koreans, the Ministry of Health and Welfare said.